RT @worldjsurg: #WJS #OpenAccess Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in #Mesenteric #Venous…
RT @worldjsurg: #WJS #OpenAccess Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in #Mesenteric #Venous…
RT @worldjsurg: #WJS #OpenAccess Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in #Mesenteric #Venous…
RT @worldjsurg: #WJS #OpenAccess Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in #Mesenteric #Venous…
RT @worldjsurg: #WJS #OpenAccess Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in #Mesenteric #Venous…
RT @worldjsurg: #WJS #OpenAccess Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in #Mesenteric #Venous…
#WJS #OpenAccess Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in #Mesenteric #Venous #Thrombosis Read the full article at: https://t.co/IFem0FcUsp #surgery